Final Report of the 2016-17 Bylaws and Policy Development Committee

Authors

Bradley C. Cannon, Rosalind Franklin University
Evan T. Robinson, Western New England University
Susan M. Stein, Pacific University
Laura Borgelt, University of Colorado
Steven C. Stoner, University of Missouri - Kansas City
Jill M. Fitzgerald, University of Connecticut
Charles T. Taylor, Northeast Ohio Medical University
Lawrence M. Brown, Chapman UniversityFollow

Document Type

Article

Publication Date

2017

Abstract

The AACP Bylaws direct the Bylaws and Policy Development Committee (BPDC) to ensure that resolutions, position papers and similar proposals to the House of Delegates that seek to establish Association policy or action are appropriate and ready for consideration by the House. The Committee is also charged with responsibility for receiving suggestions for alteration of the Association’s Articles of Incorporation or the Bylaws, preparing appropriate amendments in suitable wording that is consistent with the current Bylaws, and for presenting such proposals, together with the Committee’s recommendations, to the House of Delegates for consideration. This report contains eight adopted statements/ resolutions of policy, seven referred statements/resolutions of policy, adopted amendments to the AACP bylaws, and adopted modifications to AACP cumulative policies.

Comments

This article was originally published in American Journal of Pharmaceutical Education, volume 81, issue 1, in 2017. DOI:10.5688/ajpeS14

Recommended Citation

Final Report of the 2016-17 Bylaws and Policy Development Committee: (Reflecting actions taken by the HOD on July 19, 2017). Am J Pharm Educ. 2017;81(8):S14. doi:10.5688/ajpeS14.

Copyright

American Association of Colleges of Pharmacy